Thank you to those that attended our Investor Webinar today, 5 April 2022 at 9:00 AM AEST.
Hexima Chief Operating Officer, Dr Nicole van der Weerden, presented pezadeftide’s novel fungicidal mode of action which she recently shared at the annual meeting of the American Academy of Dermatology (AAD) on March 25th 2022 in Boston, MA.
Hexima Managing Director and CEO, Mr Michael Aldridge also discussed the company’s recent progress and upcoming milestones. The webinar concluded with a Q&A session.
View a recording of the webinar below: